K
K. William Harter
Researcher at Georgetown University
Publications - 20
Citations - 2073
K. William Harter is an academic researcher from Georgetown University. The author has contributed to research in topics: Radiosurgery & Radiation therapy. The author has an hindex of 14, co-authored 20 publications receiving 1929 citations. Previous affiliations of K. William Harter include MedStar Georgetown University Hospital.
Papers
More filters
Journal ArticleDOI
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Marshall R. Posner,Diane Hershock,Cesar R. Blajman,Elizabeth Mickiewicz,Eric Winquist,Vera Gorbounova,Sergei Tjulandin,Dong M. Shin,Kevin J. Cullen,Thomas J. Ervin,Barbara A. Murphy,Luis E. Raez,Roger B. Cohen,Monica Spaulding,Roy B. Tishler,Berta Roth,Rosana del Carmen Viroglio,Varagur Venkatesan,Ilya Romanov,Sanjiv S. Agarwala,K. William Harter,Matthew Dugan,Anthony J. Cmelak,Arnold M. Markoe,Paul W. Read,Lynn Steinbrenner,A. Dimitrios Colevas,Charles M. Norris,Robert I. Haddad +28 more
TL;DR: Patients with squamous-cell carcinoma of the head and neck who received docetaxel plus cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy had a significantly longer survival than did patients who received cisPlatin and fluoride induction chemotherapyplus cheMoradiotherapy.
Journal ArticleDOI
Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer.
Keith Unger,Christopher E. Lominska,John F. Deeken,Bruce J. Davidson,Kenneth Newkirk,Gregory J. Gagnon,Jimmy J. Hwang,Rebecca Slack,Anne-Michelle Noone,K. William Harter +9 more
TL;DR: SRS reirradiation for head-and-neck cancer is feasible and encouraging response rates with acceptable toxicity are demonstrated, as well as being associated with improved OS and concurrent chemotherapy in select patients.
Journal ArticleDOI
CyberKnife for hilar lung tumors: report of clinical response and toxicity
Keith Unger,Andrew Ju,Eric K. Oermann,Simeng Suy,Xia Yu,Saloomeh Vahdat,Deepa S. Subramaniam,K. William Harter,Sean P. Collins,Anatoly Dritschilo,Eric D. Anderson,Brian T. Collins +11 more
TL;DR: Preliminary results suggest that dose escalation alone is unlikely to enhance the therapeutic ratio of hilar lung tumors and novel approaches, such as further defining the patient population or employing the use of radiation sensitizers, should be investigated.
Journal ArticleDOI
A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
Eric K. Oermann,Rebecca Slack,Heather N Hanscom,S. Lei,Simeng Suy,Hyeon U. Park,Joy S. Kim,Benjamin A Sherer,Brian T. Collins,Andrew N. Satinsky,K. William Harter,Gerald P Batipps,Nicholas L. Constantinople,Stephen W. Dejter,William C. Maxted,James Regan,John J. Pahira,Kevin McGeagh,Reena C. Jha,Nancy A. Dawson,Anatoly Dritschilo,John H. Lynch,Sean P. Collins +22 more
TL;DR: Hypofractionated SBRT combined with IMRT offers radiobiological benefits of a large fraction boost for dose escalation and is a well tolerated treatment option for men with intermediate- to high-risk prostate cancer.
Journal ArticleDOI
Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial.
David S. Thomas,Russell J. Nauta,James E. Rodgers,G. Popescu,B S Huy Nguyen,Thomas C. Lee,Peter E. Petrucci,K. William Harter,Richard W. Holt,Anatoly Dritschilo +9 more
TL;DR: This data indicates that liver metastases from colorectal carcinoma that are notsectable but liverconfined metastases might be ablated by high‐dose radiation with a similar curative result to that obtained by treatment with chemotherapy.